NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 319 filers reported holding NOVOCURE LTD in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,452 | -62.3% | 89,926 | -3.0% | 0.02% | -60.0% |
Q2 2023 | $3,849 | +1530.9% | 92,753 | +2258.9% | 0.06% | +1733.3% |
Q1 2023 | $236 | -96.9% | 3,932 | -96.2% | 0.00% | -97.2% |
Q4 2022 | $7,611 | -99.9% | 103,763 | +13.0% | 0.11% | -13.0% |
Q3 2022 | $6,974,000 | +9.0% | 91,793 | -0.3% | 0.12% | +11.8% |
Q2 2022 | $6,401,000 | -12.0% | 92,096 | +5.0% | 0.11% | +0.9% |
Q1 2022 | $7,270,000 | +17.3% | 87,749 | +6.3% | 0.11% | 0.0% |
Q4 2021 | $6,199,000 | -34.8% | 82,568 | +1.0% | 0.11% | -40.1% |
Q3 2021 | $9,501,000 | -51.6% | 81,782 | -7.5% | 0.18% | -53.3% |
Q2 2021 | $19,616,000 | +57.5% | 88,433 | -6.1% | 0.39% | +48.9% |
Q1 2021 | $12,452,000 | -26.8% | 94,206 | -4.2% | 0.26% | -33.3% |
Q4 2020 | $17,022,000 | +50.7% | 98,370 | -3.0% | 0.39% | +33.7% |
Q3 2020 | $11,293,000 | +79.2% | 101,458 | -4.5% | 0.29% | +61.5% |
Q2 2020 | $6,303,000 | -15.4% | 106,283 | -3.9% | 0.18% | -24.8% |
Q1 2020 | $7,448,000 | -23.1% | 110,609 | -3.8% | 0.24% | -1.2% |
Q4 2019 | $9,689,000 | +9.2% | 114,979 | -3.1% | 0.24% | -13.1% |
Q3 2019 | $8,875,000 | +1.3% | 118,687 | -14.4% | 0.28% | +1.4% |
Q2 2019 | $8,765,000 | – | 138,627 | – | 0.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nordwand Advisors, LLC | 1,515,000 | $111,125,249 | 13.86% |
Invus Financial Advisors, LLC | 350,884 | $25,737,341 | 13.70% |
HARTLINE INVESTMENT CORP/ | 304,482 | $22,333,755 | 5.08% |
GREAT POINT PARTNERS LLC | 241,000 | $17,677,350 | 3.46% |
Tri Locum Partners LP | 72,400 | $5,311,000 | 2.15% |
Taylor Frigon Capital Management LLC | 42,061 | $3,085,174 | 1.75% |
HighVista Strategies LLC | 28,007 | $2,054,313 | 1.22% |
HAP Trading, LLC | 124,500 | $10,294 | 1.05% |
Private Harbour Investment Management & Counsel, LLC | 12,285 | $901,105 | 0.99% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 32,000 | $2,344,000 | 0.72% |